Can a single dose of psilocybin rewire the brain to silence chronic pain?
In short: New research suggests psilocybin may offer a non-addictive alternative to opioids for managing chronic pain. By targeting specific brain circuits rather than injury sites, this compound acts as a precise dimmer switch for pain and mood, potentially providing relief that lasts for weeks after just one dose.
Chronic pain is a global crisis affecting over 1.5 billion people, often creating a debilitating cycle alongside depression and anxiety. Researchers at the University of Pennsylvania recently explored whether psilocybin—the active compound in certain mushrooms—could disrupt this cycle. In studies involving mice with nerve injuries, a single dose of the substance reduced both physical pain and associated anxiety-like behaviors for nearly two weeks.
The mechanism behind this relief lies in the anterior cingulate cortex, a brain region responsible for processing both emotional and physical distress. Unlike traditional medications that fully activate or deactivate brain signals, psilocybin functions like a dimmer switch. It gently modulates serotonin receptors, specifically 5-HT2A and 5-HT1A, to reach an optimal level of activity. By injecting psilocin, the body’s active metabolite of psilocybin, directly into the anterior cingulate cortex, scientists achieved the same therapeutic results as systemic administration, proving the brain’s central role in the process.
While these findings are promising, experts emphasize that the research is still in its early stages. Joseph Cichon, a senior author of the study, notes that it remains uncertain how these therapies would function within the complex environment of surgical anesthesia or how multiple doses might be required for long-term solutions. Future investigations will focus on optimal dosing strategies and the brain's capacity for sustained rewiring. This work, supported by the National Institutes of Health, could eventually inform new treatments for conditions beyond pain, including post-traumatic stress disorder and addiction, offering a potential path forward that avoids the risks of dependency associated with current opioid-based pain management.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: A single dose of psilocybin may rewire the brain for lasting relief
- Also: Psilocybin
To cite this card, link to https://intellectplus.co.uk/app/health-psilocybin.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
Related
More in Drugs and medication · More in Health · Latest · A–Z · All topics